Check out the companies making headlines in pre-market trading. Robinhood — Shares of the brokerage rose more than 6% after launching the Robinhood Gold Card, a credit card that sends cash back to brokerage accounts. Concentrix — Shares of Concentrix fell nearly 4% on disappointing second-quarter profit guidance. The customer experience technology company also reiterated its full-year 2024 outlook. FourStop — Shares of FourStop plunged more than 17% after the video game retailer reported a sharp drop in fourth-quarter revenue from a year earlier. The company added that it was also cutting an undisclosed number of employees across the Quad to cut costs. Moderna — Shares of Moderna rose 3.5% after the drugmaker said it has advanced three vaccines into final-stage trials. Separately, Blackstone Life Sciences said it would provide up to $750 million to fund Moderna’s influenza program. nCino—The cloud software company reported first-quarter revenue growth of 13% year-over-year, and its stock price rose about 12%. The company’s fourth-quarter profit also beat analysts’ expectations. Krispy Kreme — Shares rose more than 2% and were up 39% from the previous day. On Tuesday, the company announced it would expand its partnership with McDonald’s to sell donuts in the fast-food chain’s restaurants, with plans to make them available nationwide by 2026. Viking Therapeutics — Shares rose nearly 3%. The stock had risen more than 15% in the previous session on encouraging trial results for a weight-loss drug. Deutsche Bank — Shares of Deutsche Bank rose 3% after Morgan Stanley upgraded the bank to “overweight.” The company said that despite the German bank’s strong growth in 2024, there may still be room for more operations. Trump Media & Technology Group – Shares of former President Donald Trump’s social media company jumped nearly 14% after making its debut as a public company a day earlier. Merck & Co. – Merck & Co. shares rose nearly 5% after the U.S. Food and Drug Administration approved Winrevair, Merck & Co.’s life-threatening lung disease treatment, for the treatment of pulmonary arterial hypertension in adults. Carnival — Shares of Carnival rose 2% ahead of the cruise operator’s first-quarter earnings report due before the bell. Analysts polled by FactSet expected a loss of 17 cents per share and quarterly revenue of $5.33 billion. Carnival’s shares surged 130% in 2023 as the industry recovered from the coronavirus pandemic, but have fallen 8% so far this year, lagging behind peers. —CNBC’s Michelle Fox, Sarah Minh and Jesse Pond contributed reporting.
